Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03639246
Title Efficacy and Safety Study of AVB-S6-500 in Patients With Platinum-Resistant Recurrent Ovarian Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Aravive Biologics
Indications

peritoneum cancer

ovarian cancer

fallopian tube cancer

Therapies

AVB-S6-500 + Paclitaxel

AVB-S6-500 + Pegylated liposomal-doxorubicin

Paclitaxel

Pegylated liposomal-doxorubicin

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.